Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04774068
Title Romidepsin and Parsaclisib for the Treatment of Relapsed or Refractory T-Cell Lymphomas
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ohio State University Comprehensive Cancer Center
Indications

peripheral T-cell lymphoma

cutaneous T cell lymphoma

Therapies

Romidepsin

Parsaclisib + Romidepsin

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.